Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation

Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation

Show other versions (1)

Atrial fibrillation remains the most common arrhythmia in clinical practice. Dronedarone is an antiarrhythmic drug for the maintenance of sinus rhythm in patients with atrial fibrillation. Dronedarone is an amiodarone derivative developed to reduce the number of extracardiovascular side effects. Dro...

Full description

Bibliographic Details
Main Authors:	Jordi Heijman, Gerd Heusch, Dobromir Dobrev
Format:	Article
Language:	English
Published:	SAGE Publishing 2013-01-01
Series:	Clinical Medicine Insights: Cardiology
Online Access:	https://doi.org/10.4137/CMC.S8445

Similar Items

Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
by: Jordi Heijman, et al.
Published: (2013-08-01)

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
by: Gheorghe-Andrei Dan, et al.
Published: (2018-12-01)

Bayesian network analyses in atrial fibrillation – A path to better therapies?
by: Jordi Heijman, et al.
Published: (2019-03-01)

Dronedarone for the treatment of atrial fibrillation and atrial flutter
by: E Maund, et al.
Published: (2010-10-01)

Dronedarone — an antiarrythmic agent with new potential for atrial fibrillation treatment
by: M. Yu. Gilyarov, et al.
Published: (2010-12-01)

Dronedarone for the management of atrial fibrillation
by: Swiss Medical Weekly
Published: (2011-02-01)

Dronedarone in the management of atrial fibrillation
by: TS Mohamed Saleem, et al.
Published: (2010-03-01)

Dronedarone for atrial fibrillation: a new therapeutic agent
by: Pawan D Patel, et al.
Published: (2009-08-01)

Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy
by: Deborah Wolbrette, et al.
Published: (2010-06-01)

Safety and Efficacy of Dronedarone in the Treatment of Atrial Fibrillation/Flutter
by: Gerald V. Naccarelli, et al.
Published: (2011-10-01)

Safety and Efficacy of Dronedarone in the Treatment of Atrial Fibrillation/Flutter
by: Gerald V. Naccarelli, et al.
Published: (2011-01-01)

Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation
by: Mengran Zhang, et al.
Published: (2021-08-01)

Managing atrial fibrillation in the elderly: critical appraisal of dronedarone
by: Trigo P, et al.
Published: (2011-12-01)

Impact of dronedarone in atrial fibrillation and flutter on stroke reduction
by: Christine Benn Christiansen, et al.
Published: (2010-03-01)

Elevated liver enzymes associated with dronedarone for atrial fibrillation
by: Kelly R Ragucci
Published: (2013-11-01)

Observational study of dronedarone in Taiwanese patients with atrial fibrillation
by: Jiunn-Lee Lin, et al.
Published: (2020-01-01)

Recurrence of atrial fibrillation following non-cardiac surgery or acute illness: A common but rarely detected complication
by: Cristian Barrios Espinosa, et al.
Published: (2020-08-01)

Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation
by: Patrick A Schweizer, et al.
Published: (2011-01-01)

Impact of controlling atrial fibrillation on outcomes relevant to the patient: focus on dronedarone
by: Chahal CAA, et al.
Published: (2012-12-01)

Cost considerations in the management of atrial fibrillation &ndash; impact of dronedarone
by: Khaykin Y, et al.
Published: (2012-03-01)

Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation
by: John Marcus Wharton, et al.
Published: (2022-02-01)

Options for antiarrhythmic therapy after surgical treatment of the atrial fibrillation
by: V. V Bazylev, et al.
Published: (2015-12-01)

Antiarrhythmic therapy in the treatment of atrial fibrillation: yesterday, today, tomorrow
by: V. I. Podzolkov, et al.
Published: (2019-06-01)

Safety issues of antiarrhythmic therapy for atrial fibrillation
by: I.I. Reznik, et al.
Published: (2024-01-01)

Sleep apnea and atrial fibrillation: Update 2020
by: Dominik Linz, et al.
Published: (2020-12-01)

Maastricht antiarrhythmic drug evaluator (MANTA): A computational tool for better understanding of antiarrhythmic drugs
by: Sutanto, H, et al.
Published: (2019)

Correction to: Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation
Published: (2023-10-01)

Correction to: Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation
Published: (2022-05-01)

Addressing the management of atrial fibrillation &ndash; a systematic review of the role of dronedarone
by: Podda GM, et al.
Published: (2012-05-01)

Atrial fibrillation does not equal atrial fibrillation: The important prognostic implications of new-onset atrial fibrillation
by: Andreas Goette, et al.
Published: (2025-02-01)

ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
by: R. D. Kurbanov, et al.
Published: (2016-01-01)

ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
by: R. D. Kurbanov, et al.
Published: (2016-01-01)

The temporal context of oral anticoagulation outcome in atrial fibrillation
by: Anke C. Fender, et al.
Published: (2022-06-01)

Pleiotropic effects of statins in atrial fibrillation patients: the evidence
by: Hadi AR Hadi, et al.
Published: (2009-06-01)

Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype
by: Inseok Hwang, et al.
Published: (2021-05-01)

Current strategies of antiarrhythmic drug therapy for paroxysmal atrial fibrillation
by: Takashi Komatsu
Published: (2012-06-01)

Present and future of antiarrhythmic therapy for atrial fibrillation: A review
by: Aida I. Tarzimanova
Published: (2024-11-01)

New possibilities of antiarrhythmic therapy of atrial fibrillation: A review
by: Aida I. Tarzimanova, et al.
Published: (2024-03-01)

Fat chance for POAF? Pericardial adipose tissue and the arrhythmogenic substrate for postoperative atrial fibrillation
by: Monika Gawałko, et al.
Published: (2022-04-01)

Surgery-related cardiac stress: A susceptibility test of late atrial fibrillation recurrence?
by: Monika Gawałko, et al.
Published: (2021-02-01)